These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19384407)

  • 1. Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.
    Cabrol C; Huzarska MA; Dinolfo C; Rodriguez MC; Reinstatler L; Ni J; Yeh LA; Cuny GD; Stein RL; Selkoe DJ; Leissring MA
    PLoS One; 2009; 4(4):e5274. PubMed ID: 19384407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
    Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
    PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-permeable, small-molecule activators of the insulin-degrading enzyme.
    Kukday SS; Manandhar SP; Ludley MC; Burriss ME; Alper BJ; Schmidt WK
    J Biomol Screen; 2012 Dec; 17(10):1348-61. PubMed ID: 22740246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
    Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
    J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE.
    Im H; Manolopoulou M; Malito E; Shen Y; Zhao J; Neant-Fery M; Sun CY; Meredith SC; Sisodia SS; Leissring MA; Tang WJ
    J Biol Chem; 2007 Aug; 282(35):25453-63. PubMed ID: 17613531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of indole-based activators of insulin degrading enzyme.
    Kraupner N; Dinh CP; Wen X; Landry V; Herledan A; Leroux F; Bosc D; Charton J; Maillard C; Warenghem S; Duplan I; Piveteau C; Hennuyer N; Staels B; Deprez B; Deprez-Poulain R
    Eur J Med Chem; 2022 Jan; 228():113982. PubMed ID: 34815130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the Activity of the Insulin-Degrading Enzyme by Aβ Peptides.
    Kemeh MM; Lazo ND
    ACS Chem Neurosci; 2023 Aug; 14(16):2935-2943. PubMed ID: 37498802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.
    de Tullio MB; Castelletto V; Hamley IW; Martino Adami PV; Morelli L; Castaño EM
    PLoS One; 2013; 8(4):e59113. PubMed ID: 23593132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-degrading enzyme hydrolyzes ATP.
    Del Carmen Camberos M; Cresto JC
    Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.
    Lauer AA; Mett J; Janitschke D; Thiel A; Stahlmann CP; Bachmann CM; Ritzmann F; Schrul B; Müller UC; Stein R; Riemenschneider M; Grimm HS; Hartmann T; Grimm MOW
    Aging Cell; 2020 Nov; 19(11):e13264. PubMed ID: 33128835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
    Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
    J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
    Pérez A; Morelli L; Cresto JC; Castaño EM
    Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
    Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective.
    de Tullio MB; Morelli L; Castaño EM
    Prion; 2008; 2(2):51-6. PubMed ID: 19098445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme.
    Abramov-Harpaz K; Miller Y
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.